Results 191 to 200 of about 5,700,334 (377)
History of the inductive sciences, from the earliest to the present time
William Whewell
openalex +2 more sources
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero+8 more
wiley +1 more source
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi+12 more
wiley +1 more source
Historical Personalities: Tweeting Standard Narratives in the History of Science [PDF]
Lee C.
europepmc +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza+3 more
wiley +1 more source
History of Oceanography, Number 08 [PDF]
Commission of Oceanography, Division of History of Science, International Union of the History and Philosophy of Science
core +1 more source
Affinity, That Elusive Dream: A Genealogy of the Chemical Revolution by Mi Gyung Kim [PDF]
Noel G. Coley
doaj
Book Review : History of Science in Latin America and the Caribbean Digital Archive [PDF]
Lambe J.
europepmc +1 more source
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh+5 more
wiley +1 more source
[History of the Memory of the Scientific Collections from the Oswaldo Cruz Institute, Fiocruz: conditions of possibility for the writing of history of science]. [PDF]
Bettamio RLAF.
europepmc +1 more source